PURPOSE: Mutations in PITX2 are associated with Axenfeld-Rieger syndrome (ARS), which involves ocular, dental, and umbilical abnormalities. Identification of cis-regulatory elements of PITX2 is important to better understand the mechanisms of disease. METHODS: Conserved noncoding elements surrounding PITX2/pitx2 were identified and examined through transgenic analysis in zebrafish; expression pattern was studied by in situ hybridization. Patient samples were screened for deletion/duplication of the PITX2 upstream region using arrays and probes. RESULTS: Zebrafish pitx2 demonstrates conserved expression during ocular and craniofacial development. Thirteen conserved noncoding sequences positioned within a gene desert as far as 1.1 Mb upstream of the human PITX2 gene were identified; 11 have enhancer activities consistent with pitx2 expression. Ten elements mediated expression in the developing brain, four regions were active during eye formation, and two sequences were associated with craniofacial expression. One region, CE4, located approximately 111 kb upstream of PITX2, directed a complex pattern including expression in the developing eye and craniofacial region, the classic sites affected in ARS. Screening of ARS patients identified an approximately 7600-kb deletion that began 106 to 108 kb upstream of the PITX2 gene, leaving PITX2 intact while removing regulatory elements CE4 to CE13. CONCLUSIONS: These data suggest the presence of a complex distant regulatory matrix within the gene desert located upstream of PITX2 with an essential role in its activity and provides a possible mechanism for the previous reports of ARS in patients with balanced translocations involving the 4q25 region upstream of PITX2 and the current patient with an upstream deletion.
PURPOSE: Mutations in PITX2 are associated with Axenfeld-Rieger syndrome (ARS), which involves ocular, dental, and umbilical abnormalities. Identification of cis-regulatory elements of PITX2 is important to better understand the mechanisms of disease. METHODS: Conserved noncoding elements surrounding PITX2/pitx2 were identified and examined through transgenic analysis in zebrafish; expression pattern was studied by in situ hybridization. Patient samples were screened for deletion/duplication of the PITX2 upstream region using arrays and probes. RESULTS:Zebrafishpitx2 demonstrates conserved expression during ocular and craniofacial development. Thirteen conserved noncoding sequences positioned within a gene desert as far as 1.1 Mb upstream of the humanPITX2 gene were identified; 11 have enhancer activities consistent with pitx2 expression. Ten elements mediated expression in the developing brain, four regions were active during eye formation, and two sequences were associated with craniofacial expression. One region, CE4, located approximately 111 kb upstream of PITX2, directed a complex pattern including expression in the developing eye and craniofacial region, the classic sites affected in ARS. Screening of ARSpatients identified an approximately 7600-kb deletion that began 106 to 108 kb upstream of the PITX2 gene, leaving PITX2 intact while removing regulatory elements CE4 to CE13. CONCLUSIONS: These data suggest the presence of a complex distant regulatory matrix within the gene desert located upstream of PITX2 with an essential role in its activity and provides a possible mechanism for the previous reports of ARS in patients with balanced translocations involving the 4q25 region upstream of PITX2 and the current patient with an upstream deletion.
Authors: Peter J Mohler; Solena Le Scouarnec; Isabelle Denjoy; John S Lowe; Pascale Guicheney; Lise Caron; Iwona M Driskell; Jean-Jacques Schott; Kris Norris; Antoine Leenhardt; Richard B Kim; Denis Escande; Dan M Roden Journal: Circulation Date: 2007-01-22 Impact factor: 29.690
Authors: Faisal Idrees; Agnes Bloch-Zupan; Samantha L Free; Daniela Vaideanu; Pamela J Thompson; Paul Ashley; Glen Brice; Paul Rutland; Maria Bitner-Glindzicz; Peng T Khaw; Scott Fraser; Sanjay M Sisodiya; Jane C Sowden Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2006-03-05 Impact factor: 3.568
Authors: Tim Footz; Faisal Idrees; Moulinath Acharya; Kathy Kozlowski; Michael A Walter Journal: Invest Ophthalmol Vis Sci Date: 2009-02-14 Impact factor: 4.799
Authors: E Engenheiro; J Saraiva; I Carreira; L Ramos; H H Ropers; E Silva; N Tommerup; Z Tümer Journal: Clin Genet Date: 2007-09-10 Impact factor: 4.438
Authors: Jinsheng Weng; Jian Luo; Xuhong Cheng; Chang Jin; Xiangtian Zhou; Jia Qu; Lili Tu; Di Ai; Dali Li; Jun Wang; James F Martin; Brad A Amendt; Mingyao Liu Journal: Proc Natl Acad Sci U S A Date: 2008-04-18 Impact factor: 11.205
Authors: E Weh; L M Reis; R C Tyler; D Bick; W J Rhead; S Wallace; T L McGregor; S K Dills; M-C Chao; J C Murray; E V Semina Journal: Clin Genet Date: 2013-09-17 Impact factor: 4.438
Authors: Meredith E Protas; Eric Weh; Tim Footz; Jay Kasberger; Scott C Baraban; Alex V Levin; L Jay Katz; Robert Ritch; Michael A Walter; Elena V Semina; Douglas B Gould Journal: Hum Mol Genet Date: 2017-09-15 Impact factor: 6.150
Authors: M Hermina Strungaru; Tim Footz; Yi Liu; Fred B Berry; Pascal Belleau; Elena V Semina; Vincent Raymond; Michael A Walter Journal: Invest Ophthalmol Vis Sci Date: 2011-09-29 Impact factor: 4.799
Authors: Ian C Welsh; Hojoong Kwak; Frances L Chen; Melissa Werner; Lindsay S Shopland; Charles G Danko; John T Lis; Min Zhang; James F Martin; Natasza A Kurpios Journal: Cell Rep Date: 2015-09-24 Impact factor: 9.423